Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,250
Closed -$413K 186
2024
Q1
$413K Hold
7,250
0.11% 113
2023
Q4
$455K Sell
7,250
-3,000
-29% -$170K 0.12% 106
2023
Q3
$592K Hold
10,250
0.2% 88
2023
Q2
$653K Hold
10,250
0.2% 87
2023
Q1
$763K Sell
10,250
-200
-2% -$15.6K 0.25% 78
2022
Q4
$839K Hold
10,450
0.29% 76
2022
Q3
$696K Hold
10,450
0.27% 84
2022
Q2
$794K Hold
10,450
0.31% 79
2022
Q1
$830K Buy
10,450
+4,800
+85% +$349K 0.31% 73
2021
Q4
$415K Hold
5,650
0.15% 112
2021
Q3
$389K Buy
+5,650
New +$429K 0.16% 105

Other funds holding INCY

Searle & Co's INCY Position: Q2 2024 in Review

Searle & Co sold out of Incyte (INCY) in Q2 2024, closing a stake of 7,250 shares — an estimated $413K sold.

Searle & Co first reported a position in INCY in Q3 2021 and held it in 11 quarters. The position peaked at $839K in Q4 2022. 583 funds tracked by Wall St. Rank hold INCY as of Q2 2024.

  • Searle & Co reported no remaining Incyte position as of Q2 2024 after selling out during the quarter.
  • Searle & Co sold 7,250 Incyte shares in Q2 2024, an estimated $413K.
  • Searle & Co first reported a position in Incyte in Q3 2021 and held it in 11 quarters.
  • Searle & Co's Incyte position peaked at $839K in Q4 2022.
  • 583 funds tracked by Wall St. Rank held Incyte as of Q2 2024.

Based on Searle & Co's 13F filing for Q2 2024, filed 30 Jul 2024.